Ariany Carvalho dos Santos

Ariany Carvalho dos Santos

Auto-generated profile, based on publicly available information

Ariany Carvalho dos Santos

Laboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados 79804-970, MS, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
Lucas Pires GuarnierLucas Pires Guarnier
Lucas Pires Guarnier
PRPaulo Vitor Moreira Romão
Paulo Vitor Moreira Romão
RPRhanany Alan Calloi Palozi
Rhanany Alan Calloi Palozi
ASAniely Oliveira Silva
Aniely Oliveira Silva
BLBethania Lorencone
Bethania Lorencone
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior
Therapeutic approaches for the treatment of dyslipidemia and atherosclerosis have radically changed in recent decades. Part of this advance undeniably stems from basic biomedical research that has provided a better understanding and identification of new therapeutic targets. The aim of this work was to develop a model to induce atherogenesis and hepato-renal impairment in female Wistar rats. The following groups received the respective treatments for 60 days: control animals, non-ovariectomized rats that received an atherogenic diet (NEAD), ovariectomized rats that received an atherogenic diet (NOAD), non-ovariectomized rats that received an atherogenic diet and oral Nω-nitro-l-arginine methyl ester hydrochloride (l-NAME; LEAD), and ovariectomized rats that received an atherogenic diet and oral l-NAME (LOAD). Animals in the NEAD, NOAD, LEAD, and LOAD groups also received methimazole and cholecalciferol daily. Urinary, biochemical, hemodynamic, and electrocardiographic parameters and renal function were assessed. Samples of the liver, heart, kidney, and arteries were collected to investigate redox status and perform histopathological analyses. All of the groups developed dyslipidemia and hepatic steatosis. Only the NEAD group developed arterial lesions that were compatible with fatty streaks. Renal function was significantly impaired in the LEAD and NOAD groups. These results indicate a viable alternative to induce atherogenesis and hepato-renal impairment in female rats.

1 June 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
AMAline Aparecida Macedo Marques
Aline Aparecida Macedo Marques
BLBethania Lorencone
Bethania Lorencone
PRPaulo Vitor Moreira Romão
Paulo Vitor Moreira Romão
Lucas Pires GuarnierLucas Pires Guarnier
Lucas Pires Guarnier
RPRhanany Alan Calloi Palozi
Rhanany Alan Calloi Palozi
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior

12 July 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
KMKaryne Moreno
Karyne Moreno
AMAline Aparecida Macedo Marques
Aline Aparecida Macedo Marques
GSGabriela Pereira da Silva
Gabriela Pereira da Silva
BLBethania Lorencone
Bethania Lorencone
CFClara Soligo Fortini
Clara Soligo Fortini
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior
Cardiovascular disease (CVD) is the leading cause of death among non-communicable diseases. There is a lack of valid animal models that mimic associations among multiple cardiovascular risk factors in humans. The present study developed an animal model that uses multiple cardiovascular risk factors—namely, hypertension, hypothyroidism, and a high-fat diet (HFD). Two models of hypertension were used: renovascular hypertension (two-kidney, one clip [2K1C]) and spontaneously hypertensive rats (SHRs). The naive group was composed of normotensive rats. Twelve weeks after surgery to induce renovascular hypertension, rats in the 2K1C and SHR groups underwent thyroidectomy. The HFD was then implemented for 6 weeks. Renal function, serum redox status, biochemical CVD markers, electrocardiographic profile, blood pressure, mesenteric vascular bed reactivity, histopathology, and morphometry were investigated. Both experimental models induced dyslipidemia, renal function impairment, and hepatic steatosis, accompanied by higher levels of different inflammatory markers and serum oxidative stress. These alterations contributed to end-organ damage in all hypertensive rats. Our findings corroborate a viable alternative model that involves multiple cardiovascular risk factors and resembles conditions that are seen in humans. Both models mimicked CVD, but our data show that SHRs exhibit more significant pathophysiological changes.

15 November 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
PZPriscila Megda João Job Zago
Priscila Megda João Job Zago
GSGustavo Ratti Da Silva
Gustavo Ratti Da Silva
EAEduarda Carolina Amaral
Eduarda Carolina Amaral
LBLorena Neris Barboza
Lorena Neris Barboza
FBFernanda de Abreu Braga
Fernanda de Abreu Braga
Francislaine Aparecida dos Reis LíveroFrancislaine Aparecida dos Reis Lívero
Francislaine Aparecida dos Reis Lívero
Croton urucurana Baill. is a native Brazilian tree, popularly known as sangra-dágua or sangue-de-dragão, based on the red resinous sap of the trunk. Its use has been transmitted through generations based on popular tradition that attributes analgesic, anti-inflammatory, and cardioprotective properties to the tree. However, its cardioprotective effects have not yet been scientifically investigated. Thus, the present study investigated the pharmacological response to an ethanol-soluble fraction from the leaves of C. urucurana in Wistar rats exposed to smoking and dyslipidemia, two important cardiovascular risk factors. The extract was evaluated by high-performance liquid chromatography. Wistar rats received a 0.5 cholesterol-enriched diet and were exposed to cigarette smoke (9 cigarettes/day for 10weeks). During the last 5weeks, the animals were orally treated with vehicle (negative control group), C. urucurana extract (30, 100, and 300mg/kg), or simvastatin (2.5mg/kg)+enalapril (15mg/kg). One group of rats that was not exposed to these risk factors was also evaluated (basal group). Electrocardiograms and systolic, diastolic, and mean blood pressure were measured. Blood was collected to measure total cholesterol, triglycerides, urea, and creatinine. The heart and kidneys were collected and processed for oxidative status and histopathological evaluation. The phytochemical analysis revealed different classes of flavonoids and condensed tannins. The model induced dyslipidemia and cardiac and renal oxidative stress and increased levels of urea and creatinine in the negative control group. Treatment with the C. urucurana extract (300mg/kg) and simvastatin+enalapril decreased cholesterol and triglyceride levels. In contrast to simvastatin+enalapril treatment, the C. urucurana extract exerted cardiac and renal antioxidant effects. No alterations of electrocardiograms, blood pressure, or histopathology were observed between groups. These findings indicate that C. urucurana exerts lipid-lowering, renal, and cardioprotective effects against oxidative stress in a preclinical model of multiple risk factors for heart disease.

8 March 2021 in Life
Verified
Journal Article
Open access
PDF file
BLBethania Lorencone
Bethania Lorencone
Lucas Pires GuarnierLucas Pires Guarnier
Lucas Pires Guarnier
RPRhanany Alan Calloi Palozi
Rhanany Alan Calloi Palozi
PRPaulo Vitor Moreira Romão
Paulo Vitor Moreira Romão
AMAline Aparecida Macedo Marques
Aline Aparecida Macedo Marques
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior
Background: Costus spicatus (Jacq.) Sw. is a medicinal species frequently prescribed for the treatment of cardiovascular diseases. This study aims to evaluate the effects of this species against the development of atherosclerosis. Methods: First, an anatomical study of the C. spicatus leaves was performed. Then, the extract (ESCS) was obtained and submitted to phytochemical analysis. Female rats were treated with a single dose of ESCS (2000 mg/kg) to assess acute toxicity. Other groups of female rats received an atherogenic diet for 60 days. After 30 days, the animals were treated orally with ESCS (30 and 300 mg/kg), rosuvastatin (5 mg/kg), or vehicle once daily for 30 days. Serum lipids oxidized low-density lipoprotein, soluble adhesion molecules, interleukins 1β and 6, and markers of renal and liver function were measured. Renal function, blood pressure, electrocardiography, and vascular reactivity were also evaluated. Arteries, heart, liver, and kidney were also collected to evaluate the tissue redox state and histopathological analysis. Results: Prolonged treatment with ESCS induces significant hypolipidemic and antioxidant effects, that prevent endothelial dysfunction and modulated the local inflammatory process, reducing the evolution of the atherosclerotic disease. Conclusions: This study provides a scientific basis for the popular use of C. spicatus for the treatment of atherosclerosis.

1 November 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
PCPamella Fukuda de Castilho
Pamella Fukuda de Castilho
FDFabiana Dantas
Fabiana Dantas
RARenata Pires De Araújo
Renata Pires De Araújo
LCLuis Henrique Almeida Castro
Luis Henrique Almeida Castro
FAFlávio Henrique Souza de Araújo
Flávio Henrique Souza de Araújo
KOKelly Mari Pires de Oliveira
Kelly Mari Pires de Oliveira